The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global In-Vitro Diagnostic Market Research Report 2024
Synopsis
In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report， we counted In-Vitro Diagnostics reagent.
The global In-Vitro Diagnostic market was valued at US$ 64460 million in 2023 and is anticipated to reach US$ 91350 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
The concentration of the market is relatively high, and the first 16 companies include Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD, JNJ, Sysmex, KHB, DaAn Gene, Leadman, BioSino, BSBE and Maccura, they occupied more than 66% of whole market. US dominates the market which occupied 43% of the whole market. Europe, continuing healthcare reforms, will increase the demand. China is going to be a major player in the future, who occupied 28% of the whole market.
This report aims to provide a comprehensive presentation of the global market for In-Vitro Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-Vitro Diagnostic.
Report Scope
The In-Vitro Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In-Vitro Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In-Vitro Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Johnson and Johnson
BD
Danaher
Thermo Fisher Scientific
Bio-Rad
Hologic
KEM-EN-TEC Diagnostics
Medtronic
Omega Diagnostics
Ortho Clinical Diagnostics
Roche
Siemens Healthineers
Sysmex
Atlas Genetics
ELITechGroup
Biomerieux
Werfen
Segment by Type
Test Equipment
Test Reagents
Segment by Application
Hospitals and Clinics
Diagnostic Center
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In-Vitro Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report， we counted In-Vitro Diagnostics reagent.
The global In-Vitro Diagnostic market was valued at US$ 64460 million in 2023 and is anticipated to reach US$ 91350 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
The concentration of the market is relatively high, and the first 16 companies include Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD, JNJ, Sysmex, KHB, DaAn Gene, Leadman, BioSino, BSBE and Maccura, they occupied more than 66% of whole market. US dominates the market which occupied 43% of the whole market. Europe, continuing healthcare reforms, will increase the demand. China is going to be a major player in the future, who occupied 28% of the whole market.
This report aims to provide a comprehensive presentation of the global market for In-Vitro Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-Vitro Diagnostic.
Report Scope
The In-Vitro Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In-Vitro Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In-Vitro Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Johnson and Johnson
BD
Danaher
Thermo Fisher Scientific
Bio-Rad
Hologic
KEM-EN-TEC Diagnostics
Medtronic
Omega Diagnostics
Ortho Clinical Diagnostics
Roche
Siemens Healthineers
Sysmex
Atlas Genetics
ELITechGroup
Biomerieux
Werfen
Segment by Type
Test Equipment
Test Reagents
Segment by Application
Hospitals and Clinics
Diagnostic Center
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In-Vitro Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-Vitro Diagnostic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Test Equipment
1.2.3 Test Reagents
1.3 Market by Application
1.3.1 Global In-Vitro Diagnostic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Center
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In-Vitro Diagnostic Market Perspective (2019-2030)
2.2 In-Vitro Diagnostic Growth Trends by Region
2.2.1 Global In-Vitro Diagnostic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 In-Vitro Diagnostic Historic Market Size by Region (2019-2024)
2.2.3 In-Vitro Diagnostic Forecasted Market Size by Region (2025-2030)
2.3 In-Vitro Diagnostic Market Dynamics
2.3.1 In-Vitro Diagnostic Industry Trends
2.3.2 In-Vitro Diagnostic Market Drivers
2.3.3 In-Vitro Diagnostic Market Challenges
2.3.4 In-Vitro Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-Vitro Diagnostic Players by Revenue
3.1.1 Global Top In-Vitro Diagnostic Players by Revenue (2019-2024)
3.1.2 Global In-Vitro Diagnostic Revenue Market Share by Players (2019-2024)
3.2 Global In-Vitro Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In-Vitro Diagnostic Revenue
3.4 Global In-Vitro Diagnostic Market Concentration Ratio
3.4.1 Global In-Vitro Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-Vitro Diagnostic Revenue in 2023
3.5 In-Vitro Diagnostic Key Players Head office and Area Served
3.6 Key Players In-Vitro Diagnostic Product Solution and Service
3.7 Date of Enter into In-Vitro Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In-Vitro Diagnostic Breakdown Data by Type
4.1 Global In-Vitro Diagnostic Historic Market Size by Type (2019-2024)
4.2 Global In-Vitro Diagnostic Forecasted Market Size by Type (2025-2030)
5 In-Vitro Diagnostic Breakdown Data by Application
5.1 Global In-Vitro Diagnostic Historic Market Size by Application (2019-2024)
5.2 Global In-Vitro Diagnostic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America In-Vitro Diagnostic Market Size (2019-2030)
6.2 North America In-Vitro Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America In-Vitro Diagnostic Market Size by Country (2019-2024)
6.4 North America In-Vitro Diagnostic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In-Vitro Diagnostic Market Size (2019-2030)
7.2 Europe In-Vitro Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe In-Vitro Diagnostic Market Size by Country (2019-2024)
7.4 Europe In-Vitro Diagnostic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In-Vitro Diagnostic Market Size (2019-2030)
8.2 Asia-Pacific In-Vitro Diagnostic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific In-Vitro Diagnostic Market Size by Region (2019-2024)
8.4 Asia-Pacific In-Vitro Diagnostic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In-Vitro Diagnostic Market Size (2019-2030)
9.2 Latin America In-Vitro Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America In-Vitro Diagnostic Market Size by Country (2019-2024)
9.4 Latin America In-Vitro Diagnostic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-Vitro Diagnostic Market Size (2019-2030)
10.2 Middle East & Africa In-Vitro Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa In-Vitro Diagnostic Market Size by Country (2019-2024)
10.4 Middle East & Africa In-Vitro Diagnostic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott In-Vitro Diagnostic Introduction
11.1.4 Abbott Revenue in In-Vitro Diagnostic Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Johnson and Johnson
11.2.1 Johnson and Johnson Company Detail
11.2.2 Johnson and Johnson Business Overview
11.2.3 Johnson and Johnson In-Vitro Diagnostic Introduction
11.2.4 Johnson and Johnson Revenue in In-Vitro Diagnostic Business (2019-2024)
11.2.5 Johnson and Johnson Recent Development
11.3 BD
11.3.1 BD Company Detail
11.3.2 BD Business Overview
11.3.3 BD In-Vitro Diagnostic Introduction
11.3.4 BD Revenue in In-Vitro Diagnostic Business (2019-2024)
11.3.5 BD Recent Development
11.4 Danaher
11.4.1 Danaher Company Detail
11.4.2 Danaher Business Overview
11.4.3 Danaher In-Vitro Diagnostic Introduction
11.4.4 Danaher Revenue in In-Vitro Diagnostic Business (2019-2024)
11.4.5 Danaher Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific In-Vitro Diagnostic Introduction
11.5.4 Thermo Fisher Scientific Revenue in In-Vitro Diagnostic Business (2019-2024)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Bio-Rad
11.6.1 Bio-Rad Company Detail
11.6.2 Bio-Rad Business Overview
11.6.3 Bio-Rad In-Vitro Diagnostic Introduction
11.6.4 Bio-Rad Revenue in In-Vitro Diagnostic Business (2019-2024)
11.6.5 Bio-Rad Recent Development
11.7 Hologic
11.7.1 Hologic Company Detail
11.7.2 Hologic Business Overview
11.7.3 Hologic In-Vitro Diagnostic Introduction
11.7.4 Hologic Revenue in In-Vitro Diagnostic Business (2019-2024)
11.7.5 Hologic Recent Development
11.8 KEM-EN-TEC Diagnostics
11.8.1 KEM-EN-TEC Diagnostics Company Detail
11.8.2 KEM-EN-TEC Diagnostics Business Overview
11.8.3 KEM-EN-TEC Diagnostics In-Vitro Diagnostic Introduction
11.8.4 KEM-EN-TEC Diagnostics Revenue in In-Vitro Diagnostic Business (2019-2024)
11.8.5 KEM-EN-TEC Diagnostics Recent Development
11.9 Medtronic
11.9.1 Medtronic Company Detail
11.9.2 Medtronic Business Overview
11.9.3 Medtronic In-Vitro Diagnostic Introduction
11.9.4 Medtronic Revenue in In-Vitro Diagnostic Business (2019-2024)
11.9.5 Medtronic Recent Development
11.10 Omega Diagnostics
11.10.1 Omega Diagnostics Company Detail
11.10.2 Omega Diagnostics Business Overview
11.10.3 Omega Diagnostics In-Vitro Diagnostic Introduction
11.10.4 Omega Diagnostics Revenue in In-Vitro Diagnostic Business (2019-2024)
11.10.5 Omega Diagnostics Recent Development
11.11 Ortho Clinical Diagnostics
11.11.1 Ortho Clinical Diagnostics Company Detail
11.11.2 Ortho Clinical Diagnostics Business Overview
11.11.3 Ortho Clinical Diagnostics In-Vitro Diagnostic Introduction
11.11.4 Ortho Clinical Diagnostics Revenue in In-Vitro Diagnostic Business (2019-2024)
11.11.5 Ortho Clinical Diagnostics Recent Development
11.12 Roche
11.12.1 Roche Company Detail
11.12.2 Roche Business Overview
11.12.3 Roche In-Vitro Diagnostic Introduction
11.12.4 Roche Revenue in In-Vitro Diagnostic Business (2019-2024)
11.12.5 Roche Recent Development
11.13 Siemens Healthineers
11.13.1 Siemens Healthineers Company Detail
11.13.2 Siemens Healthineers Business Overview
11.13.3 Siemens Healthineers In-Vitro Diagnostic Introduction
11.13.4 Siemens Healthineers Revenue in In-Vitro Diagnostic Business (2019-2024)
11.13.5 Siemens Healthineers Recent Development
11.14 Sysmex
11.14.1 Sysmex Company Detail
11.14.2 Sysmex Business Overview
11.14.3 Sysmex In-Vitro Diagnostic Introduction
11.14.4 Sysmex Revenue in In-Vitro Diagnostic Business (2019-2024)
11.14.5 Sysmex Recent Development
11.15 Atlas Genetics
11.15.1 Atlas Genetics Company Detail
11.15.2 Atlas Genetics Business Overview
11.15.3 Atlas Genetics In-Vitro Diagnostic Introduction
11.15.4 Atlas Genetics Revenue in In-Vitro Diagnostic Business (2019-2024)
11.15.5 Atlas Genetics Recent Development
11.16 ELITechGroup
11.16.1 ELITechGroup Company Detail
11.16.2 ELITechGroup Business Overview
11.16.3 ELITechGroup In-Vitro Diagnostic Introduction
11.16.4 ELITechGroup Revenue in In-Vitro Diagnostic Business (2019-2024)
11.16.5 ELITechGroup Recent Development
11.17 Biomerieux
11.17.1 Biomerieux Company Detail
11.17.2 Biomerieux Business Overview
11.17.3 Biomerieux In-Vitro Diagnostic Introduction
11.17.4 Biomerieux Revenue in In-Vitro Diagnostic Business (2019-2024)
11.17.5 Biomerieux Recent Development
11.18 Werfen
11.18.1 Werfen Company Detail
11.18.2 Werfen Business Overview
11.18.3 Werfen In-Vitro Diagnostic Introduction
11.18.4 Werfen Revenue in In-Vitro Diagnostic Business (2019-2024)
11.18.5 Werfen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
